192 related articles for article (PubMed ID: 30565037)
21. From bench to bedside: Clinical implications of KRAS status in patients with colorectal liver metastasis.
Andreatos N; Ronnekleiv-Kelly S; Margonis GA; Sasaki K; Gani F; Amini N; Wilson A; Pawlik TM
Surg Oncol; 2016 Sep; 25(3):332-8. PubMed ID: 27566041
[TBL] [Abstract][Full Text] [Related]
22. Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases.
Margonis GA; Spolverato G; Kim Y; Karagkounis G; Choti MA; Pawlik TM
Ann Surg Oncol; 2015 Dec; 22(13):4158-65. PubMed ID: 26077912
[TBL] [Abstract][Full Text] [Related]
23. MACC1 mRNA levels predict cancer recurrence after resection of colorectal cancer liver metastases.
Isella C; Mellano A; Galimi F; Petti C; Capussotti L; De Simone M; Bertotti A; Medico E; Muratore A
Ann Surg; 2013 Jun; 257(6):1089-95. PubMed ID: 23665971
[TBL] [Abstract][Full Text] [Related]
24. KRAS Mutation Status Predicts Site-Specific Recurrence and Survival After Resection of Colorectal Liver Metastases Irrespective of Location of the Primary Lesion.
Shindoh J; Nishioka Y; Yoshioka R; Sugawara T; Sakamoto Y; Hasegawa K; Hashimoto M; Kokudo N
Ann Surg Oncol; 2016 Jun; 23(6):1890-6. PubMed ID: 26786089
[TBL] [Abstract][Full Text] [Related]
25. The prognostic importance of the number of metastases in pulmonary metastasectomy of colorectal cancer.
Cho JH; Kim S; Namgung M; Choi YS; Kim HK; Zo JI; Shim YM; Kim J
World J Surg Oncol; 2015 Jul; 13():222. PubMed ID: 26205014
[TBL] [Abstract][Full Text] [Related]
26. ASO Author Reflections: Poorest Survival Outcomes in Patients with Right Colon Cancer with KRAS Mutation After Simultaneous Curative-Intent Surgery for Colorectal Cancer Liver Metastases.
Kim HS; Kim NK
Ann Surg Oncol; 2020 Dec; 27(13):5159-5160. PubMed ID: 32813206
[No Abstract] [Full Text] [Related]
27. ASO Author Reflections: The Prognostic Value of Time to Metastasis in Colorectal Liver Metastasis.
Höppener DJ; Verhoef C
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):798-799. PubMed ID: 31646452
[No Abstract] [Full Text] [Related]
28. Prognostic factors after pulmonary metastasectomy of colorectal cancers: influence of liver metastasis.
Kim S; Kim HK; Cho JH; Choi YS; Kim K; Kim J; Zo JI; Shim YM; Heo JS; Lee WY; Kim HC
World J Surg Oncol; 2016 Jul; 14(1):201. PubMed ID: 27473725
[TBL] [Abstract][Full Text] [Related]
29. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma.
Shah SA; Haddad R; Al-Sukhni W; Kim RD; Greig PD; Grant DR; Taylor BR; Langer B; Gallinger S; Wei AC
J Am Coll Surg; 2006 Mar; 202(3):468-75. PubMed ID: 16500252
[TBL] [Abstract][Full Text] [Related]
30. Colorectal Liver Metastasis Resection Outcomes Defined by Molecular Biology.
Winter D
JAMA Surg; 2015 Aug; 150(8):729. PubMed ID: 26039694
[No Abstract] [Full Text] [Related]
31. Re: A transcriptomic signature that predicts cancer recurrence following hepatectomy in patients with colorectal liver metastases.
Wang M; Li Y
Eur J Cancer; 2022 Sep; 172():405-406. PubMed ID: 35843851
[No Abstract] [Full Text] [Related]
32. Detection of DCC and Ki-ras gene alterations in colorectal carcinoma tissue as prognostic markers for liver metastatic recurrence.
Kato M; Ito Y; Kobayashi S; Isono K
Cancer; 1996 Apr; 77(8 Suppl):1729-35. PubMed ID: 8608570
[TBL] [Abstract][Full Text] [Related]
33. Tailoring ablation strategies for colorectal liver metastases based upon rat sarcoma viral oncogene mutation status.
Calandri M; Odisio BC
Chin Clin Oncol; 2019 Oct; 8(5):51. PubMed ID: 31500432
[TBL] [Abstract][Full Text] [Related]
34. Benefit of Adjuvant Chemotherapy After Curative Resection of Lung Metastasis in Colorectal Cancer.
Park HS; Jung M; Shin SJ; Heo SJ; Kim CG; Lee MG; Beom SH; Lee CY; Lee JG; Kim DJ; Ahn JB
Ann Surg Oncol; 2016 Mar; 23(3):928-35. PubMed ID: 26514121
[TBL] [Abstract][Full Text] [Related]
35. Operating to remove recurrent colorectal cancer: have we got it right?
Treasure T; Monson K; Fiorentino F; Russell C
BMJ; 2014 May; 348():g2085. PubMed ID: 25134098
[No Abstract] [Full Text] [Related]
36. Selection of patients for hepatic surgery of colorectal cancer liver metastasis based on genomic aberrations.
Bruin SC; de Ronde JJ; Wiering B; Braaf LM; de Wilt JH; Vincent AD; van Velthuysen ML; Ruers TJ; Wessels LF; van't Veer LJ
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S560-9. PubMed ID: 23783809
[TBL] [Abstract][Full Text] [Related]
37. Interactions of multiple gene alterations in colorectal liver metastases.
Kawaguchi Y; Velasco JD; Arvide EM; Wei SH; Vauthey JN
Chin Clin Oncol; 2019 Oct; 8(5):50. PubMed ID: 31500427
[TBL] [Abstract][Full Text] [Related]
38. Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis.
Margonis GA; Kim Y; Spolverato G; Ejaz A; Gupta R; Cosgrove D; Anders R; Karagkounis G; Choti MA; Pawlik TM
JAMA Surg; 2015 Aug; 150(8):722-9. PubMed ID: 26038887
[TBL] [Abstract][Full Text] [Related]
39. Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.
Margonis GA; Buettner S; Andreatos N; Kim Y; Wagner D; Sasaki K; Beer A; Schwarz C; Løes IM; Smolle M; Kamphues C; He J; Pawlik TM; Kaczirek K; Poultsides G; Lønning PE; Cameron JL; Burkhart RA; Gerger A; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ
JAMA Surg; 2018 Jul; 153(7):e180996. PubMed ID: 29799910
[TBL] [Abstract][Full Text] [Related]
40. Local recurrence of colorectal liver metastases following RFA--can we do BETA?
Dobbins C; Strickland AD; Maddern GJ
ANZ J Surg; 2010; 80(7-8):482-3. PubMed ID: 20795957
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
